Consequently, we conducted a nested case-control study using data from the Jichi Medical School (JMS) Cohort Study to examine the association between plasma adiponectin concentration and the risk for myocardial infarction over a 9-year follow-up period. Here, ADIPOQ is linked to myocardial infarction.